Make sure you can easily see the inspection window during injection
Key differences between cagrilintide and semaglutide Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways, complementary effects Gastric emptying: Cagrilintide: Very strong effect (dramatic slowing) Semaglutide: Moderate effect Combined: Maximum slowing Appetite suppression: Cagrilintide: Works via amylin/calcitonin receptors Semaglutide: Works via GLP-1 receptors in brain Combined: Dual-pathway suppression Side effects: Cagrilintide: More nausea/GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Combined: Higher side effect risk but manageable Approval status: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved CagriSema combination: Phase 3 trials Weight loss monotherapy: Cagrilintide alone: 10-12% body weight loss Semaglutide alone: 10-15% body weight loss Combined: 15-25% body weight loss Why combining cagrilintide and semaglutide works synergistically The combination targets weight loss through multiple pathways
These products mainly support surface-level skin brightening
Co-administration with exogenous GHRH produces synergistic GH release substantially greater than either agent alone a pharmacodynamic property exploited in pituitary stimulation testing
Abbreviations ALA: Alpha-lipoic acid (-lipoic acid) APO: Apocynin CAT: Catalase GPx: Glutathione peroxidase GR: Glutathione reductase GSH: Reduced glutathione GSHt: Total glutathione GSSG: Glutathione disulfide HFD: High-fat diet LFD: Low-fat diet OS: Oxidative stress OVA: Ovalbumin P: Probiotic ROS: Reactive oxygen species SFD: Standard fat diet SOD: Superoxide dismutase References Maniscalco M, Paris D, Melck DJ, DAmato M, Zedda A, Sofia M, Stellato C, Motta AJ
